Sign up
Log in
12 Health Care Stocks Moving In Monday's After-Market Session
Share
Listen to the news

Gainers

  • Agilon Health (NYSE:AGL) stock moved upwards by 17.2% to $4.98 during Monday's after-market session. The market value of their outstanding shares is at $2.0 billion.
  • Humana (NYSE:HUM) stock moved upwards by 14.64% to $292.0. The market value of their outstanding shares is at $35.2 billion.
  • RenovoRx (NASDAQ:RNXT) stock rose 13.7% to $0.9. The company's market cap stands at $31.9 million.
  • Pacira BioSciences (NASDAQ:PCRX) stock moved upwards by 13.48% to $26.0. The market value of their outstanding shares is at $1.2 billion.
  • DIH Holding US (NASDAQ:DHAI) stock moved upwards by 9.76% to $0.19. The company's market cap stands at $8.9 million.
  • Oragenics (AMEX:OGEN) shares moved upwards by 9.19% to $0.19. The company's market cap stands at $4.0 million.

Losers

  • Shattuck Labs (NASDAQ:STTK) stock fell 19.2% to $1.05 during Monday's after-market session. The market value of their outstanding shares is at $50.3 million.
  • CVRx (NASDAQ:CVRX) stock fell 14.22% to $9.9. The market value of their outstanding shares is at $257.7 million.
  • Entero Therapeutics (NASDAQ:ENTO) shares declined by 13.92% to $0.42. The company's market cap stands at $2.0 million.
  • Forte Biosciences (NASDAQ:FBRX) stock decreased by 13.68% to $4.61. The market value of their outstanding shares is at $29.4 million.
  • TNF Pharmaceuticals (NASDAQ:TNFA) shares declined by 11.78% to $0.32.
  • Bluejay Diagnostics (NASDAQ:BJDX) stock decreased by 10.14% to $6.74. The market value of their outstanding shares is at $3.7 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.